TMEM273: A Potential Drug Target and Biomarker (G170371)

Target Name: TMEM273

NCBI ID: G170371

TMEM273

TMEM273: A Potential Drug Target and Biomarker

TMEM273, short for temperature-regulated gene expression, is a non-coding RNA molecule that has been identified as a potential drug target and biomarker. It is a key regulator of gene expression in the brain and has been implicated in a number of neurological and psychiatric disorders, including Alzheimer's disease, Parkinson's disease, and schizophrenia.

TMEM273 is expressed in many different tissues and cells in the body, including the brain. It is highly expressed in the brain, making it an attractive target for drugs that can modulate its activity. The brain is a complex organ and is responsible for a wide range of functions, including decision-making, reasoning, and memory. Disruptions in brain function can lead to a range of neurological and psychiatric disorders, including Alzheimer's disease, Parkinson's disease, and schizophrenia.

TMEM273 is involved in a number of important cellular processes in the brain, including cell division, differentiation, and synaptic plasticity. It is a key regulator of the microRNA (miRNA) pathway, which is a system of post-transcriptional gene regulation that plays a critical role in brain development and function. TMEM273 has been shown to play a role in the regulation of miRNA expression and has been implicated in the development of neurodegenerative diseases.

In addition to its role in cellular processes, TMEM273 is also involved in the regulation of gene expression in response to environmental stimuli, such as temperature and changes in the level of oxygen or glucose in the brain. This makes it an attractive target for drugs that can modulate its activity in response to specific stimuli, such as those used to treat hypoxic stress in individuals with Alzheimer's disease.

TMEM273 has also been shown to play a role in the regulation of inflammation in the brain. Chronic inflammation in the brain has been implicated in a number of neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease. TMEM273 has been shown to be involved in the regulation of inflammation in the brain and has been shown to play a role in protecting against neuroinflammation.

In conclusion, TMEM273 is a promising drug target and biomarker for the treatment of a wide range of neurological and psychiatric disorders. Its role in cellular processes and its involvement in the regulation of gene expression, miRNA, temperature, and inflammation make it an attractive target for small molecules and other therapeutic agents that can modulate its activity. Further research is needed to fully understand the role of TMEM273 in neurological and psychiatric disorders and to develop effective treatments.

Protein Name: Transmembrane Protein 273

The "TMEM273 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TMEM273 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets